← All trials
NCT06854601
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2019
- Primary completion
- Jul 13, 2020
- Completion date
- Jul 13, 2020
- First posted
- Mar 3, 2025
- Last posted
- Aug 17, 2025
- Enrollment
- 333
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- PharmasoftLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.